Zobrazeno 1 - 10
of 24
pro vyhledávání: '"Carden CP"'
Publikováno v:
Lancet Oncology. Oct2008, Vol. 9 Issue 10, p1012-1017. 6p.
Publikováno v:
Journal of Clinical Oncology; 3/20/2008, Vol. 26 Issue 9, p1566-1567, 2p
Autor:
Jones RL; Drug Development Unit, Royal Marsden Hospital, London, United Kingdom. edward.kim@carolinas.org., Kim ES; Levine Cancer Institute, Carolinas HealthCare System, Charlotte, North Carolina., Nava-Parada P; Celgene Corporation, Summit, New Jersey., Alam S; Drug Development Unit, Royal Marsden Hospital, London, United Kingdom., Johnson FM; MD Anderson Cancer Center, Houston, Texas., Stephens AW; Piramal Imaging GmbH, Berlin, Germany., Simantov R; Astellas Pharma Global Development, Northbrook, Illinois., Poondru S; Astellas Pharma Global Development, Northbrook, Illinois., Gedrich R; Astellas Pharma Global Development, Northbrook, Illinois., Lippman SM; UC San Diego Moores Cancer Center, San Diego, California., Kaye SB; Drug Development Unit, Royal Marsden Hospital, London, United Kingdom., Carden CP; Drug Development Unit, Royal Marsden Hospital, London, United Kingdom.
Publikováno v:
Clinical cancer research : an official journal of the American Association for Cancer Research [Clin Cancer Res] 2015 Feb 15; Vol. 21 (4), pp. 693-700. Date of Electronic Publication: 2014 Sep 10.
Autor:
Carden CP; Cancer Research UK Cancer Therapeutics Unit, Division of Cancer Therapeutic, The Institute of Cancer Research, Sutton,United Kingdom., Stewart A, Thavasu P, Kipps E, Pope L, Crespo M, Miranda S, Attard G, Garrett MD, Clarke PA, Workman P, de Bono JS, Gore M, Kaye SB, Banerji U
Publikováno v:
Molecular cancer therapeutics [Mol Cancer Ther] 2012 Jul; Vol. 11 (7), pp. 1609-17. Date of Electronic Publication: 2012 May 03.
Autor:
Rizzo S; Section of Medicine, Institute of Cancer Research, Sutton, Surrey, United Kingdom., Hersey JM, Mellor P, Dai W, Santos-Silva A, Liber D, Luk L, Titley I, Carden CP, Box G, Hudson DL, Kaye SB, Brown R
Publikováno v:
Molecular cancer therapeutics [Mol Cancer Ther] 2011 Feb; Vol. 10 (2), pp. 325-35. Date of Electronic Publication: 2011 Jan 07.
Poly(ADP-ribose) polymerase (PARP) inhibitors: Exploiting a synthetic lethal strategy in the clinic.
Autor:
Yap TA; Drug Development Unit, Royal Marsden NHS Foundation Trust, Sutton, Surrey, United Kingdom., Sandhu SK, Carden CP, de Bono JS
Publikováno v:
CA: a cancer journal for clinicians [CA Cancer J Clin] 2011 Jan-Feb; Vol. 61 (1), pp. 31-49. Date of Electronic Publication: 2011 Jan 04.
Autor:
Brunetto AT; Royal Marsden NHS Foundation Trust, Department of Medicine, Royal Marsden Hospital, Downs Road, Sutton, Surrey, UK., Carden CP, Myerson J, Faria AL, Ashley S, Popat S, O'Brien ME
Publikováno v:
Journal of thoracic oncology : official publication of the International Association for the Study of Lung Cancer [J Thorac Oncol] 2010 Sep; Vol. 5 (9), pp. 1397-403.
Autor:
Fong PC; Drug Development Unit, Royal Marsden National Health Service Foundation Trust, Sutton, Surrey, UK., Yap TA, Boss DS, Carden CP, Mergui-Roelvink M, Gourley C, De Greve J, Lubinski J, Shanley S, Messiou C, A'Hern R, Tutt A, Ashworth A, Stone J, Carmichael J, Schellens JH, de Bono JS, Kaye SB
Publikováno v:
Journal of clinical oncology : official journal of the American Society of Clinical Oncology [J Clin Oncol] 2010 May 20; Vol. 28 (15), pp. 2512-9. Date of Electronic Publication: 2010 Apr 20.
Autor:
Carden CP; Drug Development Unit, Royal Marsden Hospital, Marsden Hospital, Sutton, Surrey SM2 5PT, UK., Sarker D, Postel-Vinay S, Yap TA, Attard G, Banerji U, Garrett MD, Thomas GV, Workman P, Kaye SB, de Bono JS
Publikováno v:
Drug discovery today [Drug Discov Today] 2010 Feb; Vol. 15 (3-4), pp. 88-97. Date of Electronic Publication: 2009 Dec 02.